Hello and Welcome to Patientsville.com, Your Source for all GASTER information. We are dedicated to provide You with GASTER safety information. Learn about GASTER serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
GASTER Safety Reports
Total GASTER reports: 14.GASTER FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 10.
Take GASTER Side Effects Survey or Share Your GASTER Story. Read More Here.
Physician from JAPAN reported GASTER problem on Apr 10, 2007. Female patient, 51 years of age, weighting 198.4 lb, was diagnosed with depression and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, enanthema, erythema, gamma-glutamyltransferase increased, mucosal erosion. GASTER dosage: unknown. During the same period patient was treated with ASTOMIN, ALINAMIN, ASPIRIN, MICARDIS, CALBLOCK, FLUITRAN, TEGRETOL. Patient was hospitalized. Patient recovered.
GASTER problem was reported by a Physician from JAPAN on Apr 17, 2007. Male patient, weighting 114.6 lb, was diagnosed with gastrointestinal haemorrhage, hyperlipidaemia, hypertension, cardiac failure congestive, coronary arterial stent insertion, myocardial infarction and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, disease recurrence, myocardial infarction, stevens-johnson syndrome, thrombosis in device. GASTER dosage: unknown. During the same period patient was treated with LIPITOR, RENIVACE, ARTIST, ASPIRIN, LUPRAC, PLAVIX. Patient was hospitalized. Patient died on 10/31/2006.
Physician from JAPAN reported GASTER problem on May 08, 2007. Male patient, 67 years of age, weighting 149.9 lb, was diagnosed with prophylaxis, pleural mesothelioma malignant and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, haemoglobin decreased, platelet count decreased. GASTER dosage: 40 MG, DAILY (1/D). During the same period patient was treated with GASMOTIN, MAGNESIUM OXIDE, PEMETREXED, CISPLATIN, PANVITAN, CYANOCOBALAMIN. Patient recovered.
GASTER problem was reported by a Physician from JAPAN on June 06, 2007. Male patient, 67 years of age, weighting 149.9 lb, was diagnosed with prophylaxis, peritoneal mesothelioma malignant and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: anaemia, platelet count decreased. GASTER dosage: 40 MG, DAILY (1/D). During the same period patient was treated with GASMOTIN, MAGNESIUM OXIDE, PEMETREXED, CISPLATIN, PANVITAN, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GASTER problem on May 29, 2006. Male patient, 72 years of age, weighting 99.21 lb, was diagnosed with infection, pyrexia, prophylaxis against dehydration, mycosis fungoides and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, chills, nausea, renal impairment. GASTER dosage: 10 MG/DAY. During the same period patient was treated with CEFAMEZIN, METILON, SOLDEM, VOLTAREN, BIOGAMMA. Patient recovered.
GASTER problem was reported by a Physician from JAPAN on Sept 16, 2004. Male patient, 35 years of age, weighting 121.3 lb, was diagnosed with gastritis, gastrointestinal stromal tumour, diarrhoea and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abscess drainage, anorexia, back pain, bile duct obstruction, bile duct stone, biliary dilatation, biliary drainage, infection. GASTER dosage: unknown. During the same period patient was treated with LOXONIN, MUCOSTA, GLEEVEC, LOPEMIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GASTER problem on Oct 12, 2006. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with abdominal pain upper, hyperventilation, osteoporosis, osteoarthritis and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, depressed level of consciousness, discomfort, hyperventilation, nausea, pallor, pulmonary oedema, shock, vomiting. GASTER dosage: 20 MG/DAY. During the same period patient was treated with MARZULENE S, DEPAS, ALFAROL, ASPARA, UNASYN, VOLTAREN, MOBIC. Patient was hospitalized. Patient recovered.
GASTER problem was reported by a Physician from JAPAN on Mar 25, 2005. Female patient, 77 years of age, was diagnosed with gastric ulcer, hypertension, hypercholesterolaemia and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: hemiparesis, thrombotic stroke. GASTER dosage: 40 MG. During the same period patient was treated with ASPIRIN, CALBLOCK, MEVALOTIN, DIOVAN, LOCHOL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GASTER problem on Oct 12, 2006. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with abdominal pain upper, hyperventilation, osteoporosis, osteoarthritis and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure decreased, blood urea increased, c-reactive protein increased, chest x-ray abnormal, depressed level of consciousness. GASTER dosage: 20 MG/DAY. During the same period patient was treated with MARZULENE S, DEPAS, ALFAROL, ASPARA, UNASYN, VOLTAREN, MOBIC. Patient was hospitalized. Patient recovered.
GASTER problem was reported by a Consumer or non-health professional from JAPAN on Apr 19, 2006. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anti-hbc antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dizziness, headache, hepatic function abnormal, liver disorder. GASTER dosage: unknown. During the same period patient was treated with FOSAMAX, FAMOTIDINE, MUCOSTA, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported GASTER problem on Apr 19, 2006. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. GASTER dosage: unknown. During the same period patient was treated with FOSAMAX, FAMOTIDINE, MUCOSTA, PREDNISOLONE. Patient was hospitalized. Patient recovered.
GASTER problem was reported by a Consumer or non-health professional from JAPAN on Apr 19, 2006. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: anti-hbc antibody positive, condition aggravated, glaucomatous optic disc atrophy, hepatic function abnormal, hepatocellular damage, liver disorder, optic neuritis retrobulbar. GASTER dosage: unknown. During the same period patient was treated with FOSAMAX, FAMOTIDINE, MUCOSTA, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported GASTER problem on June 25, 2007. Male patient, 81 years of age, was diagnosed with ventricular tachycardia and was treated with GASTER. GASTER dosage: unknown. During the same period patient was treated with BIOFERMIN, GLUCONSAN K, BISOLVON, SOTALOL. Patient died on 09/30/2006.
GASTER problem was reported by a Physician from JAPAN on July 09, 2007. Male patient, 81 years of age, was diagnosed with ventricular tachycardia and was treated with GASTER. After drug was administered, patient experienced the following problems/side effects: pneumonia. GASTER dosage: unknown. During the same period patient was treated with BIOFERMIN, GLUCONSAN K, BISOLVON, SOTALOL. Patient died on 09/30/2006.